Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

RaQualia Pharma Inc expects extraordinary profit for Q4 of FY 2013


Tuesday, 10 Dec 2013 09:30pm EST 

RaQualia Pharma Inc:Says it expects an extraordinary profit of 800 million yen for the fourth quarter of fiscal year ending Dec. 2013.Says profit recorded for the gain on selling of securities. 

Company Quote

423.0
3.0 +0.71%
30 Jan 2015